APA (7th ed.) Citation

BA, P., JT, S., S, W., WL, W., PP, L., A, F., . . . AP, C. (2026). Case Report: Complete response to the concurrent neoadjuvant radiation therapy and pembrolizumab in a locally recurrent, chemotherapy-refractory undifferentiated pleomorphic sarcoma of bone. Frontiers in oncology, 16, 1645629. https://doi.org/10.3389/fonc.2026.1645629

Chicago Style (17th ed.) Citation

BA, Patel, et al. "Case Report: Complete Response to the Concurrent Neoadjuvant Radiation Therapy and Pembrolizumab in a Locally Recurrent, Chemotherapy-refractory Undifferentiated Pleomorphic Sarcoma of Bone." Frontiers in Oncology 16 (2026): 1645629. https://doi.org/10.3389/fonc.2026.1645629.

MLA (9th ed.) Citation

BA, Patel, et al. "Case Report: Complete Response to the Concurrent Neoadjuvant Radiation Therapy and Pembrolizumab in a Locally Recurrent, Chemotherapy-refractory Undifferentiated Pleomorphic Sarcoma of Bone." Frontiers in Oncology, vol. 16, 2026, p. 1645629, https://doi.org/10.3389/fonc.2026.1645629.